A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Clinical trial NCT01524978 · COMPLETED

Trial details

NCT number: NCT01524978
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma, Neoplasms

Start date: 2012-04-12
Primary completion: 2016-10-28
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.